Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhengzhou RevoGene Industrial Co., Ltd. is a medical technology company based in Zhengzhou, China, specializing in the research, development, and manufacturing of in vitro diagnostic (IVD) products. Founded in 2020, the company quickly became a significant player in the global response to the COVID-19 pandemic by producing high-quality rapid antigen test kits. Their product line includes lateral flow assays for a variety of infectious diseases, such as Influenza A/B, Respiratory Syncytial Virus (RSV), and Mycoplasma pneumoniae. RevoGene's manufacturing facilities are certified under ISO 13485 standards, and many of their diagnostic tools have received CE marking for sale in international markets. The company focuses on providing rapid, reliable, and accessible testing solutions for both clinical and point-of-care applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhengzhou Revogene Industrial.